**Core Concept**
The question tests the knowledge of the management of anal canal cancer, specifically the role of chemoradiation in the treatment of early-stage squamous cell carcinoma. The anal canal is a unique site that combines features of the gastrointestinal and urogenital tracts, making its cancer management distinct from other gastrointestinal malignancies.

**Why the Correct Answer is Right**
The correct answer is chemoradiation, which involves the combination of chemotherapy and radiation therapy. This approach is preferred for early-stage anal canal cancer due to its high efficacy and lower morbidity compared to surgical options. Chemoradiation works by targeting the rapidly dividing cancer cells, which are more susceptible to radiation and chemotherapy agents. The concurrent administration of chemotherapy and radiation enhances the radiosensitization of cancer cells, leading to improved tumor control and survival rates.

**Why Each Wrong Option is Incorrect**
**Option A:** Surgical options, such as abdominoperineal resection (APR), are generally reserved for patients with advanced disease, recurrent disease, or those who have failed chemoradiation. While surgical resection can be curative, it often results in significant morbidity, including loss of anal function and the need for a permanent colostomy.
**Option B:** Neoadjuvant chemotherapy alone is not sufficient for the treatment of anal canal cancer, as it may not address the local tumor bulk and can lead to increased resistance to chemotherapy.
**Option C:** Radiation therapy alone can be effective for anal canal cancer but is often associated with a higher risk of local recurrence compared to chemoradiation.

**Clinical Pearl / High-Yield Fact**
For patients with anal canal cancer, the Nigro protocol, which involves chemoradiation with 5-fluorouracil (5-FU) and mitomycin-C, has been a standard of care for many years. This protocol has been shown to achieve high rates of local control and overall survival with minimal toxicity.

**Correct Answer:** C. Radiation therapy alone can be effective for anal canal cancer but is often associated with a higher risk of local recurrence compared to chemoradiation